Azacitidine + Lenalidomide Combo in the Elderly With Previously Treated AML & High-Risk MDS
Status:
Terminated
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
The purpose of the trial is to study how the elderly patients who have previously undergone
treatment for acute myeloid leukemia and high-rRisk myelodysplastic syndromes, respond to a
combined treatment with azacitidine and lenalidomide.